Siemens and BT enter into a global partnership for identity and access management

SIEMENSSiemens Medical Solutions (Siemens Med) and BT (British Telecommunications) have signed a worldwide value-added reseller agreement for the provision of identity and access management services to global clients. BT has excellent international market access and Siemens Med is a globally active supplier of a leading identity and access management suite. The new partnership consolidates the existing, successful collaborative relationship that the two companies have enjoyed for many years.

With its DirX products, Siemens offers a fully integrated identity and access management product suite. As the sole manufacturer, Siemens is able to combine its DirX products, professional services and technology into a complete solution, which also includes smartcards and physical and logical access. The system offers outstanding flexibility in the area of administration, particularly in the automated creation of user accounts and granting of associated access rights. DirX products offer leading-edge technology in terms of scalability, reliability and availability. DirX identity and access management also allows simple and effective integration with SAP systems, such as SAP Netweaver. These characteristics were decisive factors in BT's decision to collaborate with Siemens.

BT will use Siemens DirX products in client projects, which will thus benefit from BT's long-standing practical experience and international expertise in the consultancy, designing and integration of complex identity and access management (IAM) solutions. It will focus in particular on the efficiency of business processes, fulfilment of compliance criteria and advising customers on organisational aspects. Using project start-up resources such as the "Identity Management Healthcheck", BT systematically checks how well the company is prepared for IAM, so as to meet the expectations of all participants as realistically and efficiently as possible. The solution realised by BT can then be operated either on the customer’s site or as a hosted variant at one of BT’s secure data centres.

The experts from BT use worldwide standardised procedural models, methods and tools, so that BT is especially well-placed to undertake global projects. Customers can also, if they wish, take advantage of other offerings from BT’s service portfolio.

Ray Stanton, global head of BT’s business continuity, security and governance practice, said: "This ground breaking agreement underlines the ongoing strength and success of our relationship with Siemens, and brings to bear the combined skills and assets of our two organisations for the benefits of our clients in an area that is vital to the success and security of the modern organisation. BT is looking forward to developing a strong, fruitful, and long lasting partnership with Siemens, and ensuring that our customers receive a truly world class identity and access management service."

Doris Hermann, VP Security and Identity Management, Siemens AG Medical Solutions, said: "We are very excited by the opportunities to provide innovative and cost effective identity and access management services to our clients through this agreement with BT. We look forward to building on the strength of our existing relationships with BT and we are very confident that our global customers will appreciate and value our joint approach."

Thanks to this partnership, customers benefit from a unique combination: It gives them access to excellent consulting and managed services, and to a comprehensive, integrated identity and access management suite all from under one roof and backed up by worldwide support.

The partnership will be started in Germany, France, the UK and the US and then gradually expanded.

About Siemens Medical Solutions
Siemens Medical Solutions is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics – such as Diagnostic Products Corporation and Bayer Diagnostics – mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting http://www.siemens.com/medical

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...